ELAVL1 and neoplasm: Constant or inducible shRNA system reduced HuR protein level ~50% (Supplementary Fig. 2a, b), which resulted in significantly delayed tumor initiation and smaller tumor volume in vivo and fewer invaded cells in vitro (Supplementary Fig. 2c–f).